Global Knee Osteoarthritis Market Outlook 2025 - Key Vendors are Anika Therapeutics, Zimmer Biomet Holdings, Stryker Corporation, and DePuy Synthes (Johnson & Johnson) - ResearchAndMarkets.com

DUBLIN--()--The "Global Knee Osteoarthritis Market [By Treatment - Non-Surgical Treatment (NSAIDS, Corticosteroids, Hyaluronic Acid Injections & Alternate Therapies) & Surgical Treatment; By Region - North America, Europe & Asia Pacific] Outlook 2025" report has been added to ResearchAndMarkets.com's offering.

The rise in R&D activities in the global knee osteoarthritis treatment industry has led to the identification of promising options such as the use of stem cells for the treatment of knee osteoarthritis. Mesenchymal stromal cells (MSCs) is found to have the potential to regenerate knee cartilage, thereby, substantially reducing pain in knee osteoarthritis patients.

The report provides an in-depth analysis of global knee osteoarthritis market with focus on various therapeutics such as NSAIDS, Corticosteroids and Hyaluronic Acid Injections. Geographical analysis is done across leading markets in regions such as North America, Europe & Asia Pacific.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global knee osteoarthritis market.

Key Vendors

  • Anika Therapeutics Inc.
  • Zimmer Biomet Holdings Inc.
  • Stryker Corporation
  • DePuy Synthes (Johnson & Johnson)

Topics Covered

1. Executive Summary

2. Research Methodology

3. Osteoarthritis

3.1 Overview

3.1.1 Symptoms

3.1.2 Risk Factors

3.2 Stages

3.3 Diagnosis & Treatment

3.3.1 Diagnosis

3.3.2 Treatment

4. Market Analysis

4.1 Market Sizing (Actual & Forecasted)

4.2 Market Share Analysis

4.2.1 Market Share by Drugs

4.2.2 Market Share by Region

5. Market Segmentation by Treatment

5.1 Non-Surgical Treatment

5.1.1 Non-Steroidal Anti-Inflammatory Drugs

5.1.2 Corticosteroids

5.1.3 Hyaluronic Acid Injections

5.1.4 Alternate Therapies

5.1.5 Others

5.2 Surgical Treatment

6. Regional Analysis

6.1 North America

6.2 Europe

6.3 Asia Pacific

7. Market Dynamics

7.1 Industry Trends & Developments

7.1.1 Stem Cell Treatment for Osteoarthritis

7.1.2 Use of Regenerative Medicine for Treatment

7.1.3 Rise in Demand for MAKOplasty

7.1.4 Disease Modifying Drugs

7.2 Growth Drivers

7.2.1 Rising Geriatric Population

7.2.2 Prevalence of Osteoarthritis Incidences

7.2.3 Rise in Number of Obese Population

7.2.4 Favorable Reimbursement Policies

7.3 Challenges

7.3.1 Stringent Regulatory Compliance

7.3.2 Side Effects of Treatment Procedures

8. Competitive Landscape

8.1 Financial Analysis

8.2 Products Portfolio

9. Company Profiles

9.1 Anika Therapeutics Inc

9.2 Zimmer Biomet Holdings Inc.

9.3 Stryker Corporation

9.4 DePuy Synthes (Johnson & Johnson)

List of Figures

Figure 1: Research - Research Methodology

Figure 2: Stage of Knee Osteoarthritis

Figure 3: Global Knee Osteoarthritis Market Size by Value, 2015-25E (US$ Billions)

Figure 4: Global Osteoarthritis Treatment Market Share by Drugs (2018)

Figure 5: Global Osteoarthritis Treatment Market Share by Region (2018)

Figure 6: Global Osteoarthritis Treatment - NSAIDS Market Size by Value, 2017-25E (US$ Billions)

Figure 7: Global Osteoarthritis Treatment - Corticosteroids Market Size by Value, 2017-25E (US$ Billions)

Figure 8: Global Osteoarthritis Treatment - Hyaluronic Acid Injections Market Size by Value, 2017-25E (US$ Billions)

Figure 9: Global Knee Osteoarthritis Surgical Treatment Market Size by Value, 2017-25E (US$ Billions)

Figure 10: North America Knee Osteoarthritis Market Size by Value, 2018-25E (US$ Billions)

Figure 11: Europe Knee Osteoarthritis Market Size by Value, 2018-25E (US$ Billions)

Figure 12: Asia Pacific Knee Osteoarthritis Market Size by Value, 2018-25E (US$ Billions)

Figure 13: Global Ageing (65 and above) Population, 2013-18 (Millions)

Figure 14: Prevalence of Osteoarthritis by Age & Sex, 2017-18

Figure 15: Global Osteoarthritis Incidences, 2014-18 (Millions)

Figure 16: Global Obese Population, 2013-18 (Millions)

Figure 17: Anika Therapeutics, Inc. Revenue by Business Segment (FY2019E)

Figure 18: Anika Therapeutics, Inc. Net Sales, FY2015-FY2021E (US$ Millions)

Figure 19: Zimmer Biomet Holdings, Inc. Revenue by Business Segment (FY2018)

Figure 20: Zimmer Biomet Holdings, Inc. Net Sales, FY2015-FY2018 (US$ Billions)

Figure 21: Stryker Corporation Revenue by Business Segment (FY2018)

Figure 22: Stryker Corporation Net Sales, FY2015-FY2018 (US$ Billions)

Figure 23: DePuy Synthes (Johnson & Johnson) Revenue by Business Segment (FY2018)

Figure 24: DePuy Synthes (Johnson & Johnson) Net Sales, FY2015-FY2018 (US$ Billions)

List of Tables

Table 1: Analysis of Various Stages of Knee Osteoarthritis

Table 2: Osteoarthritis Treatment Landscape

Table 3: Global Knee Osteoarthritis Market Players Revenue Comparison, FY2016-FY2020E (US$ Millions)

Table 4: Global Knee Osteoarthritis Market Players Financial Analysis (FY2019E)

Table 5: Global Knee Osteoarthritis Market Therapeutics Comparative Analysis

For more information about this report visit https://www.researchandmarkets.com/r/id0f8i

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Over the Counter (OTC) Drugs, Immune Disorders Drugs, Analgesics, Infusions and Injectables , Musculoskeletal Disorders Drugs, Immunosuppressive Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Over the Counter (OTC) Drugs, Immune Disorders Drugs, Analgesics, Infusions and Injectables , Musculoskeletal Disorders Drugs, Immunosuppressive Drugs